Focal cortical and subcortical atrophy in early Parkinson's disease

Movement Disorders

Volumn 26, Issue 3, 2011, Pages 436-441

  Tinaz, Sule ^a   Courtney, Maureen G ^a   Stern, Chantal E ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cognition; Emotional dysregulation; MRI; Orbitofrontal cortex

Indexed keywords

ACCURACY; ADULT; AGED; ALZHEIMER DISEASE; ANXIETY; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN CORTEX ATROPHY; BRAIN DYSFUNCTION; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; EARLY DIAGNOSIS; FEMALE; FOCAL CORTICAL ATROPHY; FRONTAL CORTEX; GEOMETRY; HUMAN; HUNTINGTON CHOREA; MALE; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; ORBITAL CORTEX; PARIETAL CORTEX; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; PUTAMEN; SUBCORTEX; SUBCORTICAL ATROPHY; THICKNESS; VENTROLATERAL PREFRONTAL CORTEX;

AGED; ATROPHY; BRAIN MAPPING; CEREBRAL CORTEX; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 79953281479     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23453     Document Type: Article

References (39)

1. Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol 2000; 247 ( Suppl 2): 3-10.
2. Galvin JE, Lee VM, Trojanowski JQ. Synucleinopathies: clinical and pathological implications. Arch Neurol 2001; 58: 186-190.
3. Double KL, Halliday GM, McRitchie DA, Reid WG, Hely MA, Morris JG. Regional brain atrophy in idiopathic Parkinson's disease and diffuse Lewy body disease. Dementia 1996; 7: 304-313.
4. Summerfield C, Junque C, Tolosa E, et al. Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 2005; 62: 281-285.
5. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004; 127: 791-800.
6. Geng DY, Li YX, Zee CS. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease. Neurosurgery 2006; 58: 256-262.
7. Brenneis C, Seppi K, Schocke MF, Benke T, Wenning GK, Poewe W. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 2003; 18: 1132-1138.
8. Cordato NJ, Duggins AJ, Halliday GM, Morris JG, Pantelis C. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 2005; 128: 1259-1266.
9. Nagano-Saito A, Washimi Y, Arahata Y, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005; 64: 224-229.
10. Salat DH, Buckner RL, Snyder AZ, et al. Thinning of the cerebral cortex in aging. Cereb Cortex 2004; 14: 721-730.
11. Rosas HD, Liu AK, Hersch S, et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002; 58: 695-701.
12. Rosas HD, Salat DH, Lee SY, et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008; 131 (Part 4): 1057-1068.
13. Sailer M, Fischl B, Salat D, et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003; 126: 1734-1744.
14. Kuperberg GR, Broome MR, McGuire PK, et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 2003; 60: 878-888.
15. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341-355.
16. Dickerson BC, Bakkour A, Salat DH, et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 2009; 19: 497-510.
17. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
18. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease. New Jersey: MacMillan Health Care Information; 1978. p 153-163.
19. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
20. Mattis S. Dementia rating scale. Odessa, FL: Psychological Assessment Resources; 1988.
21. Grober E, Sliwinski M. Development and validation of a model for estimating premorbid verbal intelligence in the elderly. J Clin Exp Neuropsychol 1991; 13: 933-949.
22. Wechsler D. Wechsler adult intelligence scale-III. San Antonio, TX: The Psychological Corporation; 1997.
23. Spreen O, Benton AL. Neurosensory center comprehensive examination for aphasia. Victoria, BC: Univestiy of Victoria Neuropsychology Laboratory; 1977.
24. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson, AZ: Neuropsychology Press; 1993.
25. Beck AT. Beck depression inventory-II. San Antonio, TX: The Psychological Corporation; 1997.
26. Spielberger CD, Gorusch RL, Lushene R. Spielberger state trait anxiety inventory I and II. Palo Alto, CA: Consulting Psychologists Press; 1983.
27. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999; 9: 179-194.
28. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000; 97: 11050-11055.
29. Fischl B, Liu A, Dale AM. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 2001; 20: 70-80.
30. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II. Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999; 9: 195-207.
31. Fischl B, Sereno MI, Tootell RB, Dale AM. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 1999; 8: 272-284.
32. Fischl B, van der Kouwe A, Destrieux C, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004; 14: 11-22.
33. Castelo JM, Courtney MG, Melrose RJ, Stern CE. Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise. Arch Neurol 2007; 64: 1275-1280.
34. Cronin-Golomb A, Braun AE. Visuospatial dysfunction and problem solving in Parkinson's disease. Neuropsychology 1997; 11: 44-52.
35. Abe Y, Kachi T, Kato T, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003; 74: 419-422.
36. Barbas H, Ghashghaei HT, Rempel-Clower NL, Xiao D. Anatomic basis of functional specialization in prefrontal cortices in primates. In: Grafman J, editor. Handbook of neuropsychology. Amsterdam; New York: Elsevier; 2002. p 1-27.
37. Brandstadter D, Oertel WH. Depression in Parkinson's disease. Adv Neurol 2003; 91: 371-381.
38. Mayberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990; 28: 57-64.
39. Bechara A, Damasio H, Tranel D, Damasio AR. Deciding advantageously before knowing the advantageous strategy. Science 1997; 275: 1293-1295.